Paid Clinical Trials Houston

Discover 3,004 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,004

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Houston TX, Tomball TX, Galveston TX, Beaumont TXshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting

PHASE1

PHASE2

Sponsor:

Amgen

Location:

Houston TX, Tyler TX, Dallas TX, Irving TXshow 9 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

NGLY1 Natural HistoryNGLY1 Natural History

Recruiting

Sponsor:

Baylor College of Medicine

Location:

Houston TX

Code:

NCT06122766

Conditions

NGLY1 Deficiency

Eligibility Criteria

Sex: All

Age: 2 - 25

Healthy Volunteers: Not accepted

Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia AreataStudy Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata

Recruiting

EARLY_PHASE1

Sponsor:

The University of Texas Health Science Center, Houston

Location:

Houston TX

Code:

NCT05414266

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Interventions

Placebo

SADBE 5%

Allogeneic CD30.CAR-EBVSTs in Patients with Relapsed or Refractory CD30-Positive LymphomasAllogeneic CD30.CAR-EBVSTs in Patients with Relapsed or Refractory CD30-Positive Lymphomas

Recruiting

PHASE1

Sponsor:

Baylor College of Medicine

Location:

Houston TX

Code:

NCT04288726

Conditions

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Classical Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

CD30.CAR-EBVST cells

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic MigraineA Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Houston TX, Dallas TX, Lewisville TX, Flowood MSshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal AdenocarcinomaPhase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

Recruiting

PHASE2

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT03784326

Conditions

Clinical Stage II Esophageal Adenocarcinoma AJCC v8

Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8

Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Conventional Surgery

Fluorouracil

Oxaliplatin

Tiragolumab

Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerCoordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer

Recruiting

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT03058926

Conditions

Chronic Pancreatitis

Diabetes

Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Data Management and Monitoring

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).

Recruiting

PHASE2

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT06448026

Conditions

Locally Recurrent Oral Cavity Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cemiplimab

Cetuximab

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the LungsA Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Recruiting

PHASE1

PHASE2

Sponsor:

Krystal Biotech, Inc.

Location:

The Woodlands TX, New Orleans LA, Nasville TN, El Paso TXshow 4 more

Code:

NCT06228326

Conditions

Lung Cancer, Non-small Cell

Lung Cancer Metastatic

Solid Tumor, Adult

Advanced Cancer

Lung Cancer (NSCLC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KB707

Pembrolizumab (KEYTRUDA®)

Chemotherapy

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Recruiting

PHASE3

Sponsor:

VistaGen Therapeutics, Inc.

Location:

Houston TX, Austin TX, Dallas TX, Little Rock ARshow 12 more

Code:

NCT06615557

Conditions

Social Anxiety Disorder (SAD)

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Fasedienol Nasal Spray

Placebo Nasal Spray